key: cord-0887493-edjoap8k
authors: Gunsilius, Eberhard
title: Interesting news from the annual meeting of the American Society of Hematology 2020
date: 2021-09-16
journal: Memo
DOI: 10.1007/s12254-021-00733-1
sha: 13c7a856bfb5c669f2cb58c8317f963537e519a4
doc_id: 887493
cord_uid: edjoap8k

nan

) are currently tested in clinical trials and show impressive clinical results even in heavily pretreated patients and will enrich our therapeutic armamentarium in the near future, although with considerable financial toxicity for the health care systems.

What we have missed are the personal contacts and discussions with friends and colleagues. We all hope that in the foreseeable future, "real" meetings can be held again so that we can maintain or build up personal and scientific relationships.

Chronic lymphocytic leukaemia-what is new and notable in 2021, with a special focus on COVID-19. memo

New trends in autologous and allogeneic stem cell transplantation-an update from the annual ASH meeting 2020

Multiple myeloma: my highlights at ASH 2020. memo

Conflict of interest E. Gunsilius declares that he has no competing interests.